Warthin's tumor epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Warthin's tumor Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Warthin's tumor from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Biopsy
Treatment
Surgery
Cost-Effectiveness of Therapy
Case Studies
Case #1
Warthin's tumor epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Warthin's tumor epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Warthin's tumor epidemiology and demographics
CDC on Warthin's tumor epidemiology and demographics
Warthin's tumor epidemiology and demographics in the news
Blogs on Warthin's tumor epidemiology and demographics
Directions to Hospitals Treating Warthin's tumor
Risk calculators and risk factors for Warthin's tumor epidemiology and demographics

Epidemiology

The gland most likely affected is the parotid gland. Though much less likely to occur than pleomorphic adenoma, Warthin's tumor is the second most common benign parotid tumor. Warthin's tumor is more likely to occur in older adults between 60 -70 years of age. There is a slight female predilection according to recent studies, but historically it has been associated with a strong male predilection. This change is possibly due to the tumor's association with cigarette smoking and the growing use of cigarettes in women.